Are Dr Martens shares in for another kicking?

As the iconic British footwear company slumps to a near eight-month low, independent analyst Alistair Strang runs his software to spot the next trend.

28th January 2026 08:00

by Alistair Strang from Trends and Targets

Share on

Dr Martens boots, Getty

Dr. Martens Ordinary Shares (LSE:DOCS) appear poised to deliver a kicking to their share price but, in this instance, we think our usual logic may falter and produce a level at which a rebound could be anticipated.

Currently, below 65p risks triggering further reversals to an initial 61p with our secondary, if broken, at 48p and a visual match with the lows of April last year. But there is a big “however” in this scenario as it risks taking their share price below the level of trend break in June 2025, when the share price was 59p. 

We do set some store with these trend break levels, almost always suggesting closure below a trend break point will always be a bad thing. And in the future, once some amateur drama takes place below a trend break point, if the price closes above that level it allows us to indulge in pretty confident recovery ambitions.

Thus, with an argument favouring an initial 61p target, we’d be hoping for a rebound around such a level. While this thought will invariably require some lucky charms, a rebound shall be a reasonable expectation. 

If this price point breaks, while 48p is almost certain to provide a trampoline level, experience has taught us that any proper recovery can take an age as the historical trend break level of 61p shall invariably present a glass ceiling against any strong future recovery.

Of course, we can present a converse viewpoint.

Should the share price wander above just 76p, it “risks” triggering movement upward to an initial 89p with our secondary, if beaten, now at 99p. The 99p level is a visual problem, historically the share price proving itself incapable of rising above such a ceiling. However, closure above that level shall indicate the footwear company deserves a new lease of life.

docs280126.jpg

Source: Trends and Targets. Past performance is not a guide to future performance.

Alistair Strang has led high-profile and "top secret" software projects since the late 1970s and won the original John Logie Baird Award for inventors and innovators. After the financial crash, he wanted to know "how it worked" with a view to mimicking existing trading formulas and predicting what was coming next. His results speak for themselves as he continually refines the methodology.

Alistair Strang is a freelance contributor and not a direct employee of Interactive Investor. All correspondence is with Alistair Strang, who for these purposes is deemed a third-party supplier. Buying, selling and investing in shares is not without risk. Market and company movement will affect your performance and you may get back less than you invest. Neither Alistair Strang or Interactive Investor will be responsible for any losses that may be incurred as a result of following a trading idea. 

These articles are provided for information purposes only.  Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties.  The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

Related Categories

    Technical AnalysisTrading tips and ideasUK shares

Get more news and expert articles direct to your inbox